Company Filing History:
Years Active: 1993
Title: Keiji Komatsu: Innovator in Immune Complex Disease Treatment
Introduction
Keiji Komatsu is a notable inventor based in Tokorozawa, Japan. He has made significant contributions to the field of medicine, particularly in the treatment of immune complex diseases. His innovative approach has led to the development of a unique preparation that utilizes n-acetylneuraminic acid.
Latest Patents
Komatsu holds a patent for a method of treating immune complex diseases with n-acetylneuraminic acid. The patent describes a preparation that includes an injection containing specific compounds, where the active ingredient is combined with a pharmacologically acceptable carrier. This preparation can be administered through various methods, including hypodermic, intramuscular, and intravenous routes. He has 1 patent to his name.
Career Highlights
Keiji Komatsu is associated with Mect Corporation, where he has been able to apply his expertise in developing innovative medical treatments. His work has been instrumental in advancing therapeutic options for patients suffering from immune complex diseases.
Collaborations
Throughout his career, Komatsu has collaborated with notable colleagues, including Takeshi Miyata and Kazuo Takahama. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Keiji Komatsu's contributions to the field of medicine, particularly through his patent for treating immune complex diseases, highlight his role as an influential inventor. His work continues to impact the medical community positively.